Literature DB >> 27566074

In Vitro Cultivation of Primary Prostate Cancer Cells Alters the Molecular Biomarker Pattern.

Anne Caspar1, Jörg Mostertz2, Merle Leymann1, Patrick Ziegler3, Katja Evert4, Matthias Evert4, Uwe Zimmermann1, Lars-Ove Brandenburg5, Martin Burchardt1, Matthias B Stope6.   

Abstract

BACKGROUND/AIM: The high variability of primary cells propagated in vitro led us to study the expression patterns of 11 most commonly accepted and widely used biomarkers specific for prostate cancer (PC) cells in primary cell models.
MATERIALS AND METHODS: Primary PC cells from five PC patients were partially subjected to RNA preparation immediately and remaining cells were propagated up to 84 days followed by RNA preparation. Subsequently, biomarker mRNA quantification was performed by quantitative reverse transcription-polymerase chain reaction (RT-PCR) and biomarker transcript concentrations before and after cultivation of primary PC cells were compared.
RESULTS: Evaluation of androgen receptor, prostate-specific antigen, acid phosphatase, prostate-specific membrane antigen, fatty acid synthase, cytokeratin types 5/8/19, E-cadherin, epithelial cell adhesion molecule and fibroblast-specific protein 1 demonstrated temporal changes, as well as individual differences in expression, during primary PC cell propagation.
CONCLUSION: Experimental design, as well as data evaluation, may need to take under consideration the high variability of biomarker expression in primary PC cells.
Copyright © 2016 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  Prostate cancer; biomarker; primary cell culture

Mesh:

Substances:

Year:  2016        PMID: 27566074

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  5 in total

Review 1.  Clinical Factors Asssociated with Treatment Outcomes following Whole-brain Irradiation in Patients with Prostate Cancer.

Authors:  Liesa Dziggel; Steven E Schild; Theo Veninga; Amira Bajrovic; Dirk Rades
Journal:  In Vivo       Date:  2017-01-02       Impact factor: 2.155

2.  The 22Rv1 prostate cancer cell line carries mixed genetic ancestry: Implications for prostate cancer health disparities research using pre-clinical models.

Authors:  Leanne Woods-Burnham; Anamika Basu; Christina K Cajigas-Du Ross; Arthur Love; Clayton Yates; Marino De Leon; Sourav Roy; Carlos A Casiano
Journal:  Prostate       Date:  2017-10-14       Impact factor: 4.012

3.  Live cell molecular analysis of primary prostate cancer organoids identifies persistent androgen receptor signaling.

Authors:  Erika Heninger; David Kosoff; Tamara S Rodems; Nan Sethakorn; Anupama Singh; Harshitha Gungurthi; Kristin N Carlson; Bing Yang; Cole Gilsdorf; Cheri A Pasch; Dustin A Deming; Leigh Ellis; David J Beebe; David F Jarrard; Joshua M Lang
Journal:  Med Oncol       Date:  2021-09-28       Impact factor: 3.738

4.  Decellularized In Vitro Capillaries for Studies of Metastatic Tendency and Selection of Treatment.

Authors:  Outi Huttala; Desiree Loreth; Synnöve Staff; Minna Tanner; Harriet Wikman; Timo Ylikomi
Journal:  Biomedicines       Date:  2022-01-26

5.  Tumor-infiltrating lymphocytes from human prostate tumors reveal anti-tumor reactivity and potential for adoptive cell therapy.

Authors:  Sharon Yunger; Assaf Bar El; Li-At Zeltzer; Eddie Fridman; Gil Raviv; Menachem Laufer; Jacob Schachter; Gal Markel; Orit Itzhaki; Michal J Besser
Journal:  Oncoimmunology       Date:  2019-10-11       Impact factor: 8.110

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.